Picture of Zydus Lifesciences logo

ZYDUSLIFE — Zydus Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Brief: Formycon and Zydus Partner For Exclusive Licensing And Supply Agreement Of FYB206

Dec 9 (Reuters) - Formycon AG FYB.DE:

FORMYCON AND ZYDUS PARTNER FOR EXCLUSIVE LICENSING AND SUPPLY AGREEMENT OF FYB206, A BIOSIMILARTO KEYTRUDA®(PEMBROLIZUMAB),IN U.S. AND CANADA

AGREEMENT INCLUDES MID-TEENS-MILLION-EURO UPFRONT PAYMENTS

FYB206 CLINICAL DEVELOPMENT NEARLY COMPLETED, DATA EXPECTED Q1 2026

Source text: ID:nEQ5PsG4Ya

Further company coverage: FYB.DE

 (Gdansk Newsroom)

 ((((gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));;))

Recent news on Zydus Lifesciences

See all news